Editorial

November 30, 2023


Summarizing the Intentions and Outcomes of JUO 2023 Issue 3
Cheol Kwak
J Urol Oncol. 2023;21(3):181-182.

Invited Review

November 30, 2023


Influence of Body Composition on the Perioperative and Survival Outcomes of Renal Cell Carcinoma
Edouard H. Nicaise, Benjamin N. Schmeusser, Yash B. Shah, et al.
J Urol Oncol. 2023;21(3):183-199.

Topic Article

November 30, 2023


Preoperative Renal Artery Embolization Before Radical Nephrectomy for Nonmetastatic Renal Cell Carcinoma: A Propensity Score Matched Analysis
Jin Noh, Sang Hun Song, Gyoohwan Jung, et al.
J Urol Oncol. 2023;21(3):200-207.

Invited Review

November 30, 2023


The Future of Adjuvant Therapy in Renal Cell Carcinoma: Recent Insights and Prospects
Hyerim Ha, Joo Han Lim
J Urol Oncol. 2023;21(3):208-216.

Invited Review

November 30, 2023


Role of Radiotherapy in Metastatic Renal Cell Carcinomas: An Evolutionary Journey in a Misunderstood Histological Type
Chan Woo Wee, Jaeho Cho
J Urol Oncol. 2023;21(3):217-227.

Invited Review

November 30, 2023


Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023
Jiwoong Yu, Hyun Hwan Sung
J Urol Oncol. 2023;21(3):228-240.

Topic Article

November 30, 2023


Early Experience With Pembrolizumab in Bacillus Calmette-Guérin Unresponsive Non–Muscle-Invasive Bladder Cancer
Chung Un Lee, Wan Song, Minyong Kang, et al.
J Urol Oncol. 2023;21(3):241-248.

Original Article

November 30, 2023


Clinical Outcomes of Patients With Variant Histology of Urothelial Carcinoma After Radical Cystectomy
Dan Bee Lee, Jae Yeon Kim, Yun Ha Lee, et al.
J Urol Oncol. 2023;21(3):249-256.

Topic Article

November 30, 2023


Predictive Factors of Abiraterone Response in Patients With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
Jaeyoung Cho, Jungyo Suh, Dalsan You, et al.
J Urol Oncol. 2023;21(3):257-263.

Topic Article

November 30, 2023


Nonregional Lymph Node Metastasis as a Predictor of Early Progression When Using Androgen Receptor Targeting Agents in Patients With Metastatic Castration-Resistant Prostate Cancer Without Previous Chemotherapy
Sihyeon Kim, Beom Yong Rho, Dong Hyuk Kang, et al.
J Urol Oncol. 2023;21(3):264-270.

Original Article

November 30, 2023


Negative Delta-Prostate-Specific Antigen Time Ratio as Potential New Marker of Progression-Free Survival in Castration-Resistant Prostate Cancer Patients Treated With First-Line Enzalutamide or Docetaxel
Tae Hwan Kim, Seol Ho Choo, Kang Hee Shim, et al.
J Urol Oncol. 2023;21(3):271-276.

Erratum: Addition of the second author

November 30, 2023


Clinical Significance of Rab27a as a Urinary Biomarker in Patients With Bladder Cancer
Ja Yoon Ku, Md Nazmul Huda, Eu Chang Hwang, et al.
J Urol Oncol. 2023;21(3):277-277.

This archive contains links to the full-text of all issues.

Current issue

Volume 21(3); November

All issues

Vol. 21
2023

v.21(1) Mar 2023


v.21(2) Jul 2023


v.21(3) Nov 2023

The Korean Journal of Urological Oncology2003 (v1 n1) to 2022 (v22 n4)
Vol. 20
2022

v.20(1) Feb 2022

v.20(2) May 2022

v.20(3) Aug 2022

v.20(4) Nov 2022
Vol. 19
2021

v.19(1) Feb 2021

v.19(2) May 2021

v.19(3) Aug 2021

v.19(4) Nov 2021
Vol. 18
2020

v.18(1) Apr 2020

v.18(2) Aug 2020

v.18(3) Dec 2020
Vol. 17
2019

v.17(1) Apr 2019

v.17(2) Aug 2019

v.17(3) Dec 2019
Vol. 16
2018

v.16(1) Apr 2018

v.16(2) Aug 2018

v.16(3) Dec 2018
Vol. 15
2017

v.15(1) Apr 2017

v.15(2) Aug 2017

v.15(3) Dec 2017
Vol. 14
2016
v.14(1) Apr 2016

v.14(2) Aug 2016

v.14(3) Dec 2016
Vol. 13
2015
v.13(1) Apr 2015
v.13(2) Aug 2015
v.13(3) Dec 2015
Vol. 12
2014
v.12(1) Apr 2014
v.12(2) Aug 2014
v.12(3) Dec 2014
Vol. 11
2013
v.11(1) Apr 2013
v.11(2) Aug 2013
v.11(3) Dec 2013
Vol. 10
2012
v.10(1) Apr 2012
v.10(2) Aug 2012
v.10(3) Dec 2012
Vol. 9
2011
v.9(1) Apr 2011
v.9(2) Aug 2011
v.9(3) Dec 2011
Vol. 8
2010
v.8(1) Apr 2010
v.8(2) Aug 2010
v.8(3) Dec 2010
Vol. 7
2009
v.7(1) Apr 2009
v.7(2) Aug 2009
v.7(3) Dec 2009
Vol. 6
2008
v.6(1) Apr 2008
v.6(2) Aug 2008
v.6(3) Dec 2008
Vol. 5
2007
v.5(1) Apr 2007
v.5(2) Aug 2007
v.5(3) Dec 2007
Vol. 4
2006
v.4(1) Jun 2006
v.4(2) Dec 2006
Vol. 3
2005
v.3(1) Jun 2005
v.3(2) Dec 2005
Vol. 2
2004
v.2(1) Mar 2004
v.2(2) Jun 2004
v.2(3) Sep 2004
v.2(4) Dec 2004
Vol. 1
2003
v.1(1) Mar 2003
v.1(2) Jun 2003
v.1(3) Sep 2003
v.1(4) Dec 2003

Journal of
Urologic Oncology

Print ISSN: 2951-603X
Online ISSN: 2982-7043


Editorial Office
Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817,   FAX: +82-2-742-4665   Email: journal@e-juo.org                

Copyright © The Korean Urological Oncology Society.

Developed in M2PI